期刊文献+

sTREM-1和hs-CRP对COPD急性加重期患者的初始治疗效果评价 预览

Effect evaluation of sTREM-1 and hs-CRP during initial treatment for patients with chronic obstructive pulmonary disease in acute exacerbation period
在线阅读 下载PDF
分享 导出
摘要 目的:探究可溶性髓系细胞触发受体-1(sTREM-1)及超敏C反应蛋白(hs-CRP)对慢性阻塞性肺疾病急性加重期(AECOPD)患者的初始抗生素治疗效果的评估价值。方法:选取佳木斯大学附属第一医院呼吸科内科住院的48例AECOPD病人,测定病人入院第1天、第4天血清sTREM-1和hs-CRP水平,并比较入院第1天时和入院第4天的sTREM-1和hs-CRP水平的变化和区别。结果:sTREM-1和hs-CRP治疗后显著下降(P<0.05)。结论:随着应用抗生素治疗有效,AECOPD患者血清sTREM-1、hs-CRP降低,故推测二者联测可能对加重期病人抗菌素的初始治疗疗效评估有一定的临床价值。 Objective:To evaluate the effect of sTREM-1 and hs-CRP on predicting initial treatment response in chronic obstructive pulmonary disease in acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:48 cases of patients with AECOPD were selected,and sTREM-1 and hs-CRP level in1 d,4 d were determined,and compared the level changes and difference in 1 d,4 d.Results:sTREM-1 and hs-CRP were significantly reduced after treatment(P<0.05).Conclusion:With effective antibiotic treatment,sTREM-1 and hs-CRP are reduced.The united measurement may have effect on predicting initial treatment response in patients with AECOPD.
作者 钟铨 王晓茜 鲍文华 赵艳景 张君雪 仇义全 章婷 钟雅 刘甡 ZHONG Quan;WANG Xiao-xi;BAO Wen-hua;ZHAO Yan-jing;ZHANG Jun-xue;QIU Yi-quan;ZHANG Ting;ZHONG Ya;LIU Shen(The First Affiliated Hospital of Jiamusi University,Jiamusi 154003,China;The First Affiliated Hospital of Hainan Medical University,Haikou 570100,China;Hainan General Hospital,Haikou 570100,China)
出处 《黑龙江医药科学》 2018年第6期27-28,共2页 Heilongjiang Medicine and Pharmacy
基金 佳木斯大学研究生科技创新项目,编号:YM2016_036。
关键词 初始疗效 慢性阻塞性肺疾病急性加重期 超敏C反应蛋白 可溶性髓系细胞触发受体-1 acute exacerbation of chronic obstructive pulmonary disease high sensitivity C reactive protein soluble triggering receptor expressed on myeloid cells-1 initial effect
作者简介 钟铨(1990-)男,海南昌江人,在读硕士研究生;通讯作者:刘甡(1964-)男,黑龙江佳木斯人,硕士,主任医师。E-mail:526109186@qq.com。
  • 相关文献

参考文献4

二级参考文献31

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈